Skip to content
★ Sign in to follow
VC

Vyvyan Campbell

PetLife Pharmaceuticals, Inc.
Total declarations
9
Company
1
▲ Purchases (5 ops.)
€312k
▼ Sales (0 ops.)
—

Latest filing published 20 Mar 2018 for PetLife Pharmaceuticals, Inc., €3,284.

Filing timeline

BuySale
Vyvyan Campbell

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-53.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Vyvyan Campbell: trading record in brief

All filings by Vyvyan Campbell on record concern PetLife Pharmaceuticals, Inc. We count 9 filings; the first trade dates from 30 May 2015 and the latest from 28 February 2018.

The open-market record is one-sided, with 5 purchases worth €312k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants. In 2018 alone, the filings show 1 purchase and no sales.

A typical purchase (the median) is worth €23k.

On 20 March 2018 came the latest disclosure, an open-market purchase for €3,284 in PetLife Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Vyvyan Campbell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations